FREMONT, California, October 25, 2018
FREMONT, California, October 25, 2018 /PRNewswire/ --
According to a new market intelligence report by BIS Research, titled "Global Non-Invasive Prenatal Testing (NIPT) Market - Analysis and Forecast, 2018-2028", the global NIPT is anticipated to grow over $5.67 billion with 7,591,792 units by 2028. The global NIPT market is projected to grow with a CAGR of 13.07% between the years 2018 and 2028, aided by the remarkable growth in the IONA test, trisomy detection, and NGS segments.
Browse 21 market Data Tables and 225 Figures spread through 406 Slides and in-depth TOC on 'Global Non-Invasive Prenatal Testing (NIPT) Market'
Technological advancements in the healthcare industry have always played a crucial role in its overall development. Among the innumerable advancements witnessed by the industry, NIPT today stands as one of the most distinctive technologies in curbing the concerns related to genetic diseases. The recent advancements in the life science industry, such as wearable healthcare devices, sequencing technologies, regenerative medicine, and genomic technologies, supported by breakthroughs in the field of genome sequencing and molecular research have opened new and promising pathways to combat genetic diseases and reduce the overall global economic burden.
Prenatal testing has become the need of the hour owing to the increasing number of cases of genetic disorders, such as Down syndrome, spina bifida, cleft palate, sickle cell anemia, thalassemia, fragile X syndrome, and Tay-Sachs disease, among others. Further, all of these conditions are the consequences of the mutant genes and an abnormal chromosomal structure. Therefore, prenatal testing prerequisites the patient to be mentally prepared and helps them to take a decision either to continue or to abort the pregnancy. This has widened the scope of prenatal testing in the IVF market, as the chances of heredity diseases increase in cases where egg and sperm of donors are used for the fertilization process.
There are several methods in prenatal testing such as amniocentesis, chronic villus sampling, maternal serum screening, and non-invasive prenatal testing (NIPT), among others. NIPT is used for screening pregnant women who are at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18), Patau's syndrome (trisomy 13), and Turner syndrome (monosomy X). The NIPT market growth is propelling due to various factors, such as increasing demand for non-invasive diagnostic procedures, technological advancements, increasing prevalence of genetic disorders, and government initiatives for reimbursement policies, across the globe.
BIS Research Report: https://bisresearch.com/industry-report/non-invasive-prenatal-testing-market.html
According to Pushplata Patel, Analyst at BIS Research, "North America is the leading contributor to the global NIPT market. The contribution of North America to the global NIPT market was valued approximately 51.55% and 52.31% in terms of revenue and volume respectively in 2017. Fields such as the IONA test and trisomy detection application are expected to progress at significant rates. Further, the significant development in the reimbursement policies in the region is consequentially fueling the growth of NIPT market in North America. However, the region of Asia-Pacific is expected to grow at an impressive CAGR of 18.01% and 19.13% in terms of revenue and volume respectively during the forecast period (2018 - 2028). The Asia-Pacific market contributed approximately 20.12% of the total global market value in 2017."
This market intelligence report provides a multidimensional view of the global NIPT market in terms of the market size and growth potential. This research report aims at answering various aspects of the global NIPT market with the help of the key factors driving the market, threats that can inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.
Request a sample: https://bisresearch.com/requestsample?id=593&type=download
Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches, regulatory clearance, and certifications, partnerships, collaborations, business expansions as well as mergers and acquisitions, among others. The research report provides a comprehensive analysis of the product sales & manufacturers, trend analysis by segments, and demand analysis by regions.
This report is a meticulous compilation of research on more than 70 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 30 leading companies, market participants, and vendors. The report also profiles 17 companies including several key players, such as Agilent Technologies, Inc., Annoroad Gene Technology, Berry Genomics Co., Ltd., BGI Diagnosis, Centogene AG, Counsyl, Inc., Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., Next Biosciences, NIPD Genetics, PerkinElmer, Inc., Premaitha Health Plc, and Quest Diagnostics Incorporated.
Key questions answered in the report:
About BIS Research:
BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.
With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.
Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
What distinguishes BIS Research from the rest of the players is that we don't simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686